Gil Schwartzberg

LIXT

DIRECTOR · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · CIK 0001472409

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

$1.00M

COMPANIES

ACTIVE SINCE

Nov 2020

HOLDINGS NOW

100,000

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

2 backtested trades · 8 horizons

Forward-return performance of every backtestable P/S trade by Gil Schwartzberg, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	2	+0.00%	-3.69%	+1.94%	-5.64%	-5.64%	—
14d	2	+0.00%	-9.50%	+0.72%	-10.22%	-10.22%	—
30d	2	+0.00%	-18.47%	+3.18%	-21.65%	-21.65%	—
60d	2	+0.00%	-19.52%	+2.65%	-22.18%	-22.18%	—
90d	2	+100.00%	+18.21%	+8.06%	+10.14%	+10.14%	—
180d	2	+0.00%	-27.70%	+16.90%	-44.60%	-44.60%	—
1y	2	+0.00%	-56.99%	+27.60%	-84.60%	-84.60%	—
2y	2	+0.00%	-79.81%	+15.93%	-95.74%	-95.74%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

LIXT · 100,000 shares · as of Jun 30, 2021

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

FLOW · 4 buys / 0 sellsCOVERAGE · 3 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED
LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.	PURCHASEGRANT Stock grant	100,000	—	—	100,000	Jun 30, 2021	Jul 1, 2021 ↗
LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.	PURCHASEGRANT Stock grant	250,000	—	—	250,000	Apr 9, 2021	Apr 14, 2021 ↗
LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.	PURCHASE	105,264	$4.75	$500.0K	247,775	Nov 30, 2020	Dec 2, 2020 ↗
LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.	PURCHASE	105,264	$4.75	$500.0K	105,264	Nov 30, 2020	Dec 2, 2020 ↗

Other insiders · LIXT

Loading peer insiders…

About this filer

CIK 0001472409

ROLE

Director

PRIMARY

LIXT

COMPANIES

ACTIVE SINCE

Nov 2020

MARKETPEEL · /INSIDER/0001472409DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Gil Schwartzberg

The morning brief, before the bell.